Maelor to build on pharma platform
A UK-based hospital medicines group is to acquire Speciality European Pharma subsidiary Speciality European Pharma International AG (SEPI) of Switzerland for £9.3 million cash with a further payment of up to £5million subject to regulatory criteria and sales targets.
News